Cargando…

Differential cellular metabolite alterations in HaCaT cells caused by exposure to the aryl hydrocarbon receptor-binding polycyclic aromatic hydrocarbons chrysene, benzo[a]pyrene and dibenzo[a,l]pyrene

Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous in the human environment. Since they are present in crude oilfractions used for the production of rubber and plastics, consumers may come into direct dermal contacts with these compounds (e.g., via tool handles) on a daily basis. Some individual...

Descripción completa

Detalles Bibliográficos
Autores principales: Potratz, Sarah, Jungnickel, Harald, Grabiger, Stefan, Tarnow, Patrick, Otto, Wolfgang, Fritsche, Ellen, von Bergen, Martin, Luch, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616077/
https://www.ncbi.nlm.nih.gov/pubmed/28959603
http://dx.doi.org/10.1016/j.toxrep.2016.09.003
_version_ 1783266718311776256
author Potratz, Sarah
Jungnickel, Harald
Grabiger, Stefan
Tarnow, Patrick
Otto, Wolfgang
Fritsche, Ellen
von Bergen, Martin
Luch, Andreas
author_facet Potratz, Sarah
Jungnickel, Harald
Grabiger, Stefan
Tarnow, Patrick
Otto, Wolfgang
Fritsche, Ellen
von Bergen, Martin
Luch, Andreas
author_sort Potratz, Sarah
collection PubMed
description Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous in the human environment. Since they are present in crude oilfractions used for the production of rubber and plastics, consumers may come into direct dermal contacts with these compounds (e.g., via tool handles) on a daily basis. Some individual PAHs are identified as genotoxic mutagens thereby prompting particular toxicological and environmental concern. Among this group, benzo[a]pyrene (BAP) constitutes a model carcinogen which is also used as reference compound for risk assessment purposes. It acts as a strong agonist of the aryl hydrocarbon receptor (AHR) and becomes metabolically activated toward mutagenic and carcinogenic intermediates by cytochrome P450-dependent monooxygenases (CYPs). While BAP has been exhaustively characterized with regard to its toxicological properties, there is much less information available for other PAHs. We treated an AHR-proficient immortal human keratinocyte cell line (i.e., HaCaT) with three selected PAHs: BAP, chrysene (CRY) and dibenzo[a,l]pyrene (DALP). Compound-mediated alterations of endogenous metabolites were investigated by an LC–MS/MS-based targeted approach. To examine AHR-dependent changes of the measured metabolites, AHR-deficient HaCaT knockdown cells (AHR-KD) were used for comparison. Our results reveal that 24 metabolites are sufficient to separate the PAH-exposed cells from untreated controls by application of a multivariate model. Alterations in the metabolomics profiles caused by each PAH show influences on the energy and lipid metabolism of the cells indicating reduced tricarboxylic acid (TCA) cycle activity and β-oxidation. Up-regulation of sphingomyelin levels after exposure to BAP and DALP point to pro-apoptotic processes caused by these two potent PAHs. Our results suggest that in vitro metabolomics can serve as tool to develop bioassays for application in hazard assessment.
format Online
Article
Text
id pubmed-5616077
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-56160772017-09-28 Differential cellular metabolite alterations in HaCaT cells caused by exposure to the aryl hydrocarbon receptor-binding polycyclic aromatic hydrocarbons chrysene, benzo[a]pyrene and dibenzo[a,l]pyrene Potratz, Sarah Jungnickel, Harald Grabiger, Stefan Tarnow, Patrick Otto, Wolfgang Fritsche, Ellen von Bergen, Martin Luch, Andreas Toxicol Rep Article Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous in the human environment. Since they are present in crude oilfractions used for the production of rubber and plastics, consumers may come into direct dermal contacts with these compounds (e.g., via tool handles) on a daily basis. Some individual PAHs are identified as genotoxic mutagens thereby prompting particular toxicological and environmental concern. Among this group, benzo[a]pyrene (BAP) constitutes a model carcinogen which is also used as reference compound for risk assessment purposes. It acts as a strong agonist of the aryl hydrocarbon receptor (AHR) and becomes metabolically activated toward mutagenic and carcinogenic intermediates by cytochrome P450-dependent monooxygenases (CYPs). While BAP has been exhaustively characterized with regard to its toxicological properties, there is much less information available for other PAHs. We treated an AHR-proficient immortal human keratinocyte cell line (i.e., HaCaT) with three selected PAHs: BAP, chrysene (CRY) and dibenzo[a,l]pyrene (DALP). Compound-mediated alterations of endogenous metabolites were investigated by an LC–MS/MS-based targeted approach. To examine AHR-dependent changes of the measured metabolites, AHR-deficient HaCaT knockdown cells (AHR-KD) were used for comparison. Our results reveal that 24 metabolites are sufficient to separate the PAH-exposed cells from untreated controls by application of a multivariate model. Alterations in the metabolomics profiles caused by each PAH show influences on the energy and lipid metabolism of the cells indicating reduced tricarboxylic acid (TCA) cycle activity and β-oxidation. Up-regulation of sphingomyelin levels after exposure to BAP and DALP point to pro-apoptotic processes caused by these two potent PAHs. Our results suggest that in vitro metabolomics can serve as tool to develop bioassays for application in hazard assessment. Elsevier 2016-09-16 /pmc/articles/PMC5616077/ /pubmed/28959603 http://dx.doi.org/10.1016/j.toxrep.2016.09.003 Text en © 2016 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Potratz, Sarah
Jungnickel, Harald
Grabiger, Stefan
Tarnow, Patrick
Otto, Wolfgang
Fritsche, Ellen
von Bergen, Martin
Luch, Andreas
Differential cellular metabolite alterations in HaCaT cells caused by exposure to the aryl hydrocarbon receptor-binding polycyclic aromatic hydrocarbons chrysene, benzo[a]pyrene and dibenzo[a,l]pyrene
title Differential cellular metabolite alterations in HaCaT cells caused by exposure to the aryl hydrocarbon receptor-binding polycyclic aromatic hydrocarbons chrysene, benzo[a]pyrene and dibenzo[a,l]pyrene
title_full Differential cellular metabolite alterations in HaCaT cells caused by exposure to the aryl hydrocarbon receptor-binding polycyclic aromatic hydrocarbons chrysene, benzo[a]pyrene and dibenzo[a,l]pyrene
title_fullStr Differential cellular metabolite alterations in HaCaT cells caused by exposure to the aryl hydrocarbon receptor-binding polycyclic aromatic hydrocarbons chrysene, benzo[a]pyrene and dibenzo[a,l]pyrene
title_full_unstemmed Differential cellular metabolite alterations in HaCaT cells caused by exposure to the aryl hydrocarbon receptor-binding polycyclic aromatic hydrocarbons chrysene, benzo[a]pyrene and dibenzo[a,l]pyrene
title_short Differential cellular metabolite alterations in HaCaT cells caused by exposure to the aryl hydrocarbon receptor-binding polycyclic aromatic hydrocarbons chrysene, benzo[a]pyrene and dibenzo[a,l]pyrene
title_sort differential cellular metabolite alterations in hacat cells caused by exposure to the aryl hydrocarbon receptor-binding polycyclic aromatic hydrocarbons chrysene, benzo[a]pyrene and dibenzo[a,l]pyrene
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616077/
https://www.ncbi.nlm.nih.gov/pubmed/28959603
http://dx.doi.org/10.1016/j.toxrep.2016.09.003
work_keys_str_mv AT potratzsarah differentialcellularmetabolitealterationsinhacatcellscausedbyexposuretothearylhydrocarbonreceptorbindingpolycyclicaromatichydrocarbonschrysenebenzoapyreneanddibenzoalpyrene
AT jungnickelharald differentialcellularmetabolitealterationsinhacatcellscausedbyexposuretothearylhydrocarbonreceptorbindingpolycyclicaromatichydrocarbonschrysenebenzoapyreneanddibenzoalpyrene
AT grabigerstefan differentialcellularmetabolitealterationsinhacatcellscausedbyexposuretothearylhydrocarbonreceptorbindingpolycyclicaromatichydrocarbonschrysenebenzoapyreneanddibenzoalpyrene
AT tarnowpatrick differentialcellularmetabolitealterationsinhacatcellscausedbyexposuretothearylhydrocarbonreceptorbindingpolycyclicaromatichydrocarbonschrysenebenzoapyreneanddibenzoalpyrene
AT ottowolfgang differentialcellularmetabolitealterationsinhacatcellscausedbyexposuretothearylhydrocarbonreceptorbindingpolycyclicaromatichydrocarbonschrysenebenzoapyreneanddibenzoalpyrene
AT fritscheellen differentialcellularmetabolitealterationsinhacatcellscausedbyexposuretothearylhydrocarbonreceptorbindingpolycyclicaromatichydrocarbonschrysenebenzoapyreneanddibenzoalpyrene
AT vonbergenmartin differentialcellularmetabolitealterationsinhacatcellscausedbyexposuretothearylhydrocarbonreceptorbindingpolycyclicaromatichydrocarbonschrysenebenzoapyreneanddibenzoalpyrene
AT luchandreas differentialcellularmetabolitealterationsinhacatcellscausedbyexposuretothearylhydrocarbonreceptorbindingpolycyclicaromatichydrocarbonschrysenebenzoapyreneanddibenzoalpyrene